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Phytochemicals have long demonstrated anti-obesity properties in
adipocytes. Their ability, however, to induce browning in white adipose
tissue is only beginning to emerge. We have recently established that the
white adipocyte cell line, 3T3-L1, is capable of beiging under beta-
adrenergic conditions. Using this information, we sought to investigate if the
plant steroid guggulsterone (GS) can induce beiging in 3T3-L1s. 3T3-L1
preadipocytes were differentiated using established protocols
supplemented with rosiglitazone and thyroid hormone. Direct effects of GS
were measured by treating mature 3T3-L1s for 24 hours. Indirect effects
were measured by treating mature 3T3-L1s with conditioned media from
GS-treated RAW 264.7 macrophages. Direct treatment of 3T3-L1s with GS
resulted in increased lipolysis, increased mitochondrial activity (11%), and
increased peroxisome proliferator-activated receptor gamma coactivator 1-
alpha (PGC1α) levels by 250% more than control. 3T3-L1s also
demonstrated an increase in uncoupling protein 1 (UCP1) expression by
200% and beige marker, T-box protein 1 (TBX1) expression by 80% more
than control. Furthermore, this was accompanied by increased levels of G
protein-coupled bile acid receptor (TGR5) and its downstream target
iodothyronine deiodinase 2 (DIO2). Treatment of RAW 264.7 macrophages
with GS induced a 60% increase in catecholamine release into the media
compared to control. Using this conditioned media from macrophages, 3T3-
L1 adipocytes increased the expression of DIO2 and UCP1 following 24
hours of incubation. Results from this study demonstrate that GS can
potentially induce beiging in white adipose tissue through two distinct
mechanisms: (1) direct signaling through the TGR5-cAMP-DIO2 pathway
and (2) indirectly through stimulating catecholamine release in
macrophages. Thus, it is reasonable to conclude that GS may improve the
metabolic capacity of adipose tissue thereby counteracting the effects of
obesity.
Abstract
Research Goals
• Determine if the anti-obesity phytochemical, guggulsterone, can 
promote mitochondrial biogenesis and beiging in 3T3-L1 adipocytes.
• Investigate if guggulsterone mediates mitochondrial biogenesis 
through direct or indirect signaling. 
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Conclusions
GS signaling
Working Model
GS appears to have 2 distinct effects on adipocyte beiging:
1) Direct signaling in adipocytes leading to upregulation of thermogenic/ 
beiging makers  and enhanced mitochondrial biogenesis. This effect 
appears to be partly mediated through TGR5 signaling.
2) Indirect signaling in adipocytes through macrophage M2
polarization and catecholamine secretion.
Direct Effects of GS on 3T3-L1 Adipocytes
Indirect Effects of GS on 3T3-L1 Adipocytes
GS induces mitochondrial biogenesis
GS induces adipocyte beiging
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GS protects against LPS-injury in RAW 264.7 macrophages
GS induces catecholamine secretion in RAW 264.7 macrophages that can upregulate 
UCP1 in adipocytes 
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Phytochemicals may induce beiging through nuclear receptor activation.
GS treatment appears to 
upregulate TGR5-DIO2 pathway 
in 3T3-L1s.
GS decreases adipogenesis
Control Iso 10mM
GS 25μMGS 6.25μM
